Summary
The AI-generated statements about prednisone-associated swelling/fluid retention and associated presentations are not verifiable against the provided FDA label excerpts because the excerpts do not explicitly support these specific claims (e.g., facial/hand puffiness pattern, dose/duration likelihood, clot presentation, and specific respiratory/throat tightness criteria). Several statements are therefore unsupported rather than demonstrably aligned with label language.
Category Scores
Accurate Statements
Prednisone can cause fluid retention as a side effect.
Supported by FDA label excerpt: "Common adverse reactions ... include fluid retention" and "Corticosteroids can cause elevation of blood pressure, salt, and water retention..." (Sections 6 and 5.3).
Prednisone can make the body retain more sodium and water.
Supported by FDA label excerpt: "Corticosteroids can cause elevation of blood pressure, salt, and water retention..." (Section 5.3).
Unsupported Statements
Prednisone can cause swelling.
The label excerpt mentions "fluid retention" rather than explicitly stating "swelling" as a general symptom; the provided excerpts do not directly equate these terms.
Prednisone can cause swelling most often through fluid retention.
Label excerpt supports fluid retention but does not specify that swelling occurs "most often" via fluid retention.
Prednisone-related swelling may appear as puffiness in the face.
No provided label excerpt describes facial puffiness as a manifestation of prednisone-related swelling.
Prednisone-related swelling may occur as swelling in the hands.
No provided label excerpt describes hand swelling as a manifestation of prednisone-related fluid retention.
Prednisone can cause weight gain from retained fluid.
Label excerpt states "increased appetite and weight gain" and "fluid retention" but does not link weight gain specifically to retained fluid.
Prednisone-related swelling is more likely when doses are higher.
The provided excerpts do not state a dose-response relationship for swelling/fluid retention.
Prednisone-related swelling is more likely when treatment lasts longer.
The provided excerpts do not state that swelling/fluid retention likelihood increases with longer duration.
Prednisone can increase fluid volume in the body.
The label excerpt addresses "salt and water retention" and "fluid retention" but does not explicitly state "increase fluid volume".
Swelling can be associated with serious reactions when it comes with trouble breathing, wheezing, or throat tightness.
The label excerpt provided does not connect swelling to these specific symptom clusters as prednisone-related serious reactions.
Swelling with lips, tongue, or face swelling with hives may indicate a serious reaction.
The label excerpt provided mentions rare anaphylaxis/hypersensitivity but does not describe this specific clinical presentation or connect it to swelling/hives.
One-sided leg swelling with pain or shortness of breath (could signal a clot) is a concerning presentation when assessing swelling.
The provided excerpts do not mention clot-specific assessment guidance for swelling.
Contradictions
Important Omissions
If discussing hypersensitivity/anaphylaxis or serious reactions, the label excerpt provided specifies contraindication in hypersensitivity and notes "Rare instances of anaphylaxis have occurred" but the AI claims provided instead offer symptom-based guidance not present in the excerpts.
Importance:
Moderate
Monitoring guidance relevant to fluid retention (e.g., "body weight" and routine labs including potassium; and BP) is not referenced by the AI statements.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The core adverse effect link (fluid retention; salt and water retention) is supported. However, multiple specific symptom-pattern, likelihood, and clot/serious-reaction presentation claims are unsupported by the provided label excerpts, reducing on-label accuracy.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Not Aligned
Primary Issue
Several specific claims (facial/hand puffiness patterns, dose/duration likelihood, weight gain attributed to retained fluid, and detailed serious-reaction symptom combinations) are not supported by the provided prescribing information excerpts.
Suggested Improvement
Conform to label-supported phrasing about "fluid retention" and "salt and water retention" and avoid adding symptom patterns, likelihood modifiers, or clot/serious-reaction criteria unless explicitly stated in the provided label excerpts (e.g., reference rare anaphylaxis without providing unsupported symptom-cluster guidance).